Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1304606
                    [Title] => A second hard look at glaucoma
                    [Summary] => 
Patients rarely see glaucoma coming, so clearly states Dr. Roselle R. Villa-Lucas, Pfizer medical manager for ophthalmology.

                    [DatePublished] => 2014-03-25 00:00:00
                    [ColumnID] => 133914
                    [Focus] => 0
                    [AuthorID] => 1096607
                    [AuthorName] =>  Ching M. Alano
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

PHILIPPINE GLAUCOMA FOUNDATION

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1304606
                    [Title] => A second hard look at glaucoma
                    [Summary] => 
Patients rarely see glaucoma coming, so clearly states Dr. Roselle R. Villa-Lucas, Pfizer medical manager for ophthalmology.

                    [DatePublished] => 2014-03-25 00:00:00
                    [ColumnID] => 133914
                    [Focus] => 0
                    [AuthorID] => 1096607
                    [AuthorName] =>  Ching M. Alano
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

A second hard look at glaucoma

By Ching M. Alano | March 25, 2014 - 12:00am

Patients rarely see glaucoma coming, so clearly states Dr. Roselle R. Villa-Lucas, Pfizer medical manager for ophthalmology.

Health And Family